COMPANY

TherapyX

HQ: Buffalo, NY source · therapyxinc.com ↗ · Mid-Atlantic

Keywords: protein therapeutics vaccine infectious disease gonorrhea

Location: Buffalo, NY · source · Oct 15, 2026

Profile checked Oct 10, 2026

37NIH grants

Timeline

Aug 14, 2025 Grant Government grant — SBIR: $1M (annual award, as published), announced Aug 14, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
Apr 11, 2025 Grant Government grant — SBIR: $959,868 (annual award, as published), announced Apr 11, 2025. Agency: NIH/NIDDK. Source: government award database. source ↗

Funding

Last 2 years.

Aug 14, 2025 Government grant — SBIR: $1M (annual award, as published), announced Aug 14, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
Apr 11, 2025 Government grant — SBIR: $959,868 (annual award, as published), announced Apr 11, 2025. Agency: NIH/NIDDK. Source: government award database. source ↗

NIH awards 37

Annual award amounts. Total $26.3M.

Jul 23, 2024 NIH award 5SB1AI104067-08 FY2024: $1,000,000 awarded for that fiscal year; activity SB1 (SBIR); PI AUCI, DOMINICK; recipient as written: THERAPYX, INC., BUFFALO, NY. Therapy and Prophylaxis for Genital Tract Infectio source ↗
Mar 25, 2024 NIH award 5R44DK117687-05 FY2024: $960,296 awarded for that fiscal year; activity R44 (SBIR); PI AUCI, DOMINICK; recipient as written: THERAPYX, INC., BUFFALO, NY. IL-10NanoCap® for Therapy of Familial Adenomatous Po source ↗
Aug 21, 2023 NIH award 2SB1AI104067-07 FY2023: $1,000,000 awarded for that fiscal year; activity SB1 (SBIR); PI AUCI, DOMINICK; recipient as written: THERAPYX, INC., BUFFALO, NY. Therapy and Prophylaxis for Genital Tract Infectio source ↗
May 31, 2023 NIH award 2R44DK117687-04 FY2023: $1,201,534 awarded for that fiscal year; activity R44 (SBIR); PI AUCI, DOMINICK; recipient as written: THERAPYX, INC., BUFFALO, NY. IL-10NanoCap® for Therapy of Familial Adenomatous source ↗
Jun 8, 2022 NIH award 5R44AI115877-06 FY2022: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI AUCI, DOMINICK; recipient as written: THERAPYX, INC., BUFFALO, NY. Experimental Gonococcal Vaccine source ↗
Apr 25, 2022 NIH award 5R44AI104067-06 FY2022: $915,331 awarded for that fiscal year; activity R44 (SBIR); PI AUCI, DOMINICK; recipient as written: THERAPYX, INC., BUFFALO, NY. Therapy and Prophylaxis for Genital Tract Infection source ↗
Feb 22, 2022 NIH award 1R43AI170069-01 FY2022: $300,000 awarded for that fiscal year; activity R43 (SBIR); PI LIU, YINGRU; recipient as written: THERAPYX, INC., BUFFALO, NY. OMV vaccine against Gonorrhea source ↗
Jun 29, 2021 NIH award 5R44AI115877-05 FY2021: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI AUCI, DOMINICK; recipient as written: THERAPYX, INC., BUFFALO, NY. Experimental Gonococcal Vaccine source ↗
Apr 23, 2021 NIH award 5R44AI104067-05 FY2021: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI AUCI, DOMINICK; recipient as written: THERAPYX, INC., BUFFALO, NY. Therapy and Prophylaxis for Genital Tract Infectio source ↗
Mar 8, 2021 NIH award 5R44DK117687-03 FY2021: $847,546 awarded for that fiscal year; activity R44 (SBIR); PI AUCI, DOMINICK; recipient as written: THERAPYX, INC., BUFFALO, NY. IL-10NanoCap® for Therapy of Familial Adenomatous Po source ↗
Jul 15, 2020 NIH award 2R44AI115877-04 FY2020: $807,210 awarded for that fiscal year; activity R44 (SBIR); PI AUCI, DOMINICK; recipient as written: THERAPYX, INC., BUFFALO, NY. Experimental Gonococcal Vaccine source ↗
May 1, 2020 NIH award 2R44AI104067-04A1 FY2020: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI AUCI, DOMINICK; recipient as written: THERAPYX, INC., BUFFALO, NY. Therapy and Prophylaxis for Genital Tract Infect source ↗
Feb 27, 2020 NIH award 4R44DK117687-02 FY2020: $858,320 awarded for that fiscal year; activity R44 (SBIR); PI AUCI, DOMINICK; recipient as written: THERAPYX, INC., BUFFALO, NY. IL-10NanoCap® for Therapy of Familial Adenomatous Po source ↗
Jul 31, 2019 NIH award 1R43AI147718-01 FY2019: $239,162 awarded for that fiscal year; activity R43 (SBIR); PI LIU, YINGRU; recipient as written: THERAPYX, INC., BUFFALO, NY. Encapsulated anti-IL-10 for the immune therapy of gonor source ↗
May 31, 2019 NIH award 5R44AI080009-07 FY2019: $999,998 awarded for that fiscal year; activity R44 (SBIR); PI AUCI, DOMINICK; recipient as written: THERAPYX, INC., BUFFALO, NY. Delivery of Nanoencapsulated TGFbeta and ATRA for th source ↗
Mar 7, 2019 NIH award 1R44DK117687-01A1 FY2019: $388,880 awarded for that fiscal year; activity R44 (SBIR); PI AUCI, DOMINICK; recipient as written: THERAPYX, INC., BUFFALO, NY. IL-10NanoCap® for Therapy of Familial Adenomatous source ↗
Jun 8, 2018 NIH award 1R43AT009800-01 FY2018: $320,159 awarded for that fiscal year; activity R43 (SBIR); PI AUCI, DOMINICK; recipient as written: THERAPYX, INC., BUFFALO, NY. PLGA encapsulated polyphenols to ameliorate IBD. source ↗
Apr 30, 2018 NIH award 5R44AI080009-06 FY2018: $999,998 awarded for that fiscal year; activity R44 (SBIR); PI AUCI, DOMINICK; recipient as written: THERAPYX, INC., BUFFALO, NY. Delivery of Nanoencapsulated TGFbeta and ATRA for th source ↗
Jan 5, 2018 NIH award 5R44AI115877-03 FY2018: $988,631 awarded for that fiscal year; activity R44 (SBIR); PI LIU, YINGRU; recipient as written: THERAPYX, INC., BUFFALO, NY. Experimental Gonococcal Vaccine source ↗
Jun 20, 2017 NIH award 2R44AI080009-05A1 FY2017: $999,998 awarded for that fiscal year; activity R44 (SBIR); PI AUCI, DOMINICK; recipient as written: THERAPYX, INC., BUFFALO, NY. Delivery of Nanoencapsulated TGFbeta and ATRA for source ↗
Feb 10, 2017 NIH award 2R44AI115877-02 FY2017: $805,248 awarded for that fiscal year; activity R44 (SBIR); PI LIU, YINGRU; recipient as written: THERAPYX, INC., BUFFALO, NY. Experimental Gonococcal Vaccine source ↗
Sep 2, 2016 NIH award 1R43DK106938-01A1 FY2016: $295,831 awarded for that fiscal year; activity R43 (SBIR); PI AUCI, DOMINICK; recipient as written: THERAPYX, INC., BUFFALO, NY. Oral sustained-release IL-10 microspheres for ther source ↗
Apr 27, 2015 NIH award 5R44AI104067-03 FY2015: $749,000 awarded for that fiscal year; activity R44 (SBIR); PI LIU, YINGRU; recipient as written: THERAPYX, INC., BUFFALO, NY. Therapy and Prophylaxis for Genital Tract Infection source ↗
Dec 17, 2014 NIH award 1R43AI115877-01 FY2015: $271,000 awarded for that fiscal year; activity R43 (SBIR); PI LIU, YINGRU; recipient as written: THERAPYX, INC., BUFFALO, NY. Experimental Gonococcal Vaccine source ↗
Jun 6, 2014 NIH award 2R44AI104067-02 FY2014: $749,000 awarded for that fiscal year; activity R44 (SBIR); PI LIU, YINGRU; recipient as written: THERAPYX, INC., BUFFALO, NY. Therapy and Prophylaxis for Genital Tract Infection source ↗
Mar 18, 2013 NIH award 5R44AI080009-04 FY2013: $999,998 awarded for that fiscal year; activity R44 (SBIR); PI AUCI, DOMINICK L; recipient as written: THERAPYX, INC., BUFFALO, NY. Delivery of Nanoencapsulated TGFbeta and ATRA for source ↗
Jan 31, 2013 NIH award 1R43AI104067-01A1 FY2013: $300,000 awarded for that fiscal year; activity R43 (SBIR); PI LIU, YINGRU; recipient as written: THERAPYX, INC., BUFFALO, NY. Therapy and Prophylaxis for Genital Tract Infection source ↗
Mar 8, 2012 NIH award 5R44AI080009-03 FY2012: $999,998 awarded for that fiscal year; activity R44 (SBIR); PI CONWAY, THOMAS F; recipient as written: THERAPYX, INC., BUFFALO, NY. Delivery of Nanoencapsulated TGFbeta and ATRA for source ↗
Mar 29, 2011 NIH award 2R44AI080009-02A1 FY2011: $999,998 awarded for that fiscal year; activity R44 (SBIR); PI CONWAY, THOMAS F; recipient as written: THERAPYX, INC., BUFFALO, NY. Delivery of Nanoencapsulated TGFbeta and ATRA fo source ↗
Jul 18, 2008 NIH award 1R43AI080009-01 FY2008: $172,500 awarded for that fiscal year; activity R43 (SBIR); PI CONWAY, THOMAS F; recipient as written: THERAPYX, INC., BUFFALO, NY. Delivery of Nanoencapsulated TGFbeta and ATRA for source ↗